683 Capital Management, LLC - Q3 2023 holdings

$1.29 Billion is the total value of 683 Capital Management, LLC's 157 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .

 Value Shares↓ Weighting
NewSHARKNINJA INC$30,134,000650,000
+100.0%
2.34%
NewGE HEALTHCARE TECHNOLOGIES I$28,917,000425,000
+100.0%
2.25%
NCR NewNCR CORP NEW$16,182,000600,000
+100.0%
1.26%
NewPHINIA INC$13,395,000500,000
+100.0%
1.04%
TGTX NewTG THERAPEUTICS INC$11,286,0001,350,000
+100.0%
0.88%
GTX NewGARRETT MOTION INC$11,032,0001,400,000
+100.0%
0.86%
C NewCITIGROUP INCput$10,282,500250,000
+100.0%
0.80%
SE NewSEA LTDsponsord ads$8,790,000200,000
+100.0%
0.68%
FYBR NewFRONTIER COMMUNICATIONS PARE$7,042,500450,000
+100.0%
0.55%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$5,638,10065,000
+100.0%
0.44%
NewARIS MNG CORP$5,272,3282,315,900
+100.0%
0.41%
VST NewVISTRA CORPput$4,977,000150,000
+100.0%
0.39%
NYCB NewNEW YORK CMNTY BANCORP INCput$4,536,000400,000
+100.0%
0.35%
BWA NewBORGWARNER INCput$4,037,000100,000
+100.0%
0.31%
NewSAREPTA THERAPEUTICS INCnote 1.250% 9/1$3,364,4103,000,000
+100.0%
0.26%
MRNA NewMODERNA INCcall$3,098,70030,000
+100.0%
0.24%
NewSOLENO THERAPEUTICS INC$2,567,37087,000
+100.0%
0.20%
CVNA NewCARVANA COcl a$2,099,00050,000
+100.0%
0.16%
ALNY NewALNYLAM PHARMACEUTICALS INCput$1,771,00010,000
+100.0%
0.14%
NewHILLEVAX INC$1,630,140121,200
+100.0%
0.13%
GOSS NewGOSSAMER BIO INC$1,437,5291,726,139
+100.0%
0.11%
IOVA NewIOVANCE BIOTHERAPEUTICS INCcall$1,137,500250,000
+100.0%
0.09%
NewAMC ENTMT HLDGS INCcl a new$87,89011,000
+100.0%
0.01%
NewAMC ENTMT HLDGS INCput$87,890100,000
+100.0%
0.01%
NewFREIGHTOS LTD$24,84010,800
+100.0%
0.00%
NewMARTI TECHNOLOGIES INC*w exp 99/99/999$1,810100,000
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IRSA INVERSIONES Y REP S A42Q3 20232.9%
CRESUD S A C I F Y A39Q3 20233.3%
ENOVA INTL INC34Q3 20238.2%
UNIQURE NV28Q3 20234.1%
INSPIRED ENTMT INC28Q3 20232.3%
MICRON TECHNOLOGY INC26Q1 20233.2%
GALMED PHARMACEUTICALS LTD25Q1 20201.2%
FENNEC PHARMACEUTICALS INC25Q3 20230.9%
CARVANA CO24Q3 202314.2%
ALNYLAM PHARMACEUTICALS INC24Q2 20223.2%

View 683 Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
683 Capital Management, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AxonPrime Infrastructure Acquisition CorpFebruary 14, 2023441,1382.9%
DIRTT ENVIRONMENTAL SOLUTIONS LTDFebruary 14, 2023218,490-
Hawks Acquisition CorpFebruary 14, 20231,979,5928.6%
MARINUS PHARMACEUTICALS, INC.February 14, 202390,0000.2%
SQZ Biotechnologies CoFebruary 14, 20231,330,8894.5%
Trajectory Alpha Acquisition Corp.February 14, 20231,484,7998.6%
Concord Acquisition CorpSeptember 26, 20221,550,6495.5%
Archer Aviation Inc.Sold outFebruary 14, 202200.0%
Hippo Holdings Inc.Sold outFebruary 14, 202200.0%
Joby Aviation, Inc.Sold outFebruary 14, 202200.0%

View 683 Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-01
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View 683 Capital Management, LLC's complete filings history.

Compare quarters

Export 683 Capital Management, LLC's holdings